Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval

Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval By Julie Steenhuysen and Carl O'donnell June 11, 2021 9:16 PM UTC Updated June 11, 2021 ... Read More

FDA adviser resigns over approval of new Alzheimer’s drug

A member of a US Food and Drug Administration advisory committee said Wednesday he had resigned over the agency’s approval of a new Alzheimer’s drug. The FDA approved aducanumab, to be sold ... Read More

Member of FDA’s expert panel resigns over Alzheimer’s therapy approval

With Aduhelm, the story is also more complicated than the FDA just rebuking the expert panel. The FDA granted the Biogen therapy what’s called an accelerated approval, based not on firm evidence ... Read More

Third member of FDA advisory panel resigns over Alzheimer's drug approval - NBC News

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency's decision to approve Biogen Inc's Alzheimer's disease treatment ... Read More

A third FDA panel member resigns over Alzheimer's drug approval | STAT

A third member of a Food and Drug Administration expert panel has resigned over the agency’s contentious approval of the Biogen Alzheimer’s therapy this week, STAT writes. Read More

Third member of FDA advisory panel resigns over Alzheimer’s drug approval - The Hill

A third member of a Food and Drug Administration (FDA) expert advisory panel has resigned over the agency’s controversial approval of an Alzheimer’s drug this week. In a resignation letter ... Read More

Third member of US FDA advisory panel resigns over Alzheimer's drug approval - Fox Business

Third member of US FDA advisory panel resigns over Alzheimer's drug approval The FDA gave the drug "accelerated approval," based on evidence that it can reduce a likely contributor to Alzheimer ... Read More

Third Member of FDA Panel Resigns Over Approval of Alzheimer's Drug - Business Insider

A third member of an FDA expert panel has resigned over the agency's accelerated approval of a new Alzheimer's drug. The committee voted against approving the treatment. The FDA isn't required to ... Read More

Third member of U.S. FDA advisory panel resigns over Alzheimer's drug approval - Nasdaq

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency's decision to approve Biogen Inc's Alzheimer's disease treatment ... Read More

Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval - Metro US

(Reuters) – A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s ... Read More